This review aims to summarize the latest evidence of medical and surgical treatment options for patients with relapsing testicular germ cell tumors.
Depending on International Germ Cell Cancer Classification Group risk classification 10-50% of patients with metastatic TGCT develop relapse which needs further multimodality treatment.